PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials

标题
PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials
作者
关键词
HR, + BC, HER2, + BC, Triple negative BC, PARP inhibitors, PI3K-AKT-mTOR pathway, PI3K-mTOR inhibitors
出版物
PHARMACOLOGY & THERAPEUTICS
Volume 175, Issue -, Pages 91-106
出版商
Elsevier BV
发表日期
2017-02-17
DOI
10.1016/j.pharmthera.2017.02.037

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started